top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Drug resistance in epilepsy
Drug resistance in epilepsy
Autore Foundation Novartis
Edizione [1st ed.]
Pubbl/distr/stampa New York : , : Wiley, , 2003
Descrizione fisica 1 online resource (254 pages)
Disciplina 616.853061
Altri autori (Persone) BockGregory
GoodeJamie
Collana Novartis Foundation Symposia
Soggetto topico Epilepsy - drug therapy
ATP Binding Cassette Transporter, Subfamily B - metabolism
Drug Resistance
Soggetto genere / forma Congress.
ISBN 0-470-84635-6
9786610554881
1-280-55488-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Mechanisms of Drug Resistance in Epilepsy
Drug Resistance in Epilepsy
Novartis Foundation Symposium 243 - Mechanisms of Drug Resistance in Epilepsy - Lessons from Oncology
Record Nr. UNINA-9910265943103321
Foundation Novartis  
New York : , : Wiley, , 2003
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug resistance in epilepsy
Drug resistance in epilepsy
Autore Foundation Novartis
Edizione [1st ed.]
Pubbl/distr/stampa New York : , : Wiley, , 2003
Descrizione fisica 1 online resource (254 pages)
Disciplina 616.853061
Altri autori (Persone) BockGregory
GoodeJamie
Collana Novartis Foundation Symposia
Soggetto topico Epilepsy - drug therapy
ATP Binding Cassette Transporter, Subfamily B - metabolism
Drug Resistance
Soggetto genere / forma Congress.
ISBN 0-470-84635-6
9786610554881
1-280-55488-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Mechanisms of Drug Resistance in Epilepsy
Drug Resistance in Epilepsy
Novartis Foundation Symposium 243 - Mechanisms of Drug Resistance in Epilepsy - Lessons from Oncology
Record Nr. UNINA-9910829945003321
Foundation Novartis  
New York : , : Wiley, , 2003
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug resistance in epilepsy
Drug resistance in epilepsy
Autore Foundation Novartis
Edizione [1st ed.]
Pubbl/distr/stampa New York : , : Wiley, , 2003
Descrizione fisica 1 online resource (254 pages)
Disciplina 616.853061
Altri autori (Persone) BockGregory
GoodeJamie
Collana Novartis Foundation Symposia
Soggetto topico Epilepsy - drug therapy
ATP Binding Cassette Transporter, Subfamily B - metabolism
Drug Resistance
Soggetto genere / forma Congress.
ISBN 0-470-84635-6
9786610554881
1-280-55488-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Mechanisms of Drug Resistance in Epilepsy
Drug Resistance in Epilepsy
Novartis Foundation Symposium 243 - Mechanisms of Drug Resistance in Epilepsy - Lessons from Oncology
Record Nr. UNINA-9910876579603321
Foundation Novartis  
New York : , : Wiley, , 2003
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pharmacoresistance in epilepsy : from genes and molecules to promising therapies / / Luisa Rocha, Esper A. Cavalheiro, editors
Pharmacoresistance in epilepsy : from genes and molecules to promising therapies / / Luisa Rocha, Esper A. Cavalheiro, editors
Edizione [1st ed. 2013.]
Pubbl/distr/stampa New York, : Springer, c2013
Descrizione fisica 1 online resource (332 p.)
Disciplina 616.853061
Altri autori (Persone) RochaLuisa
CavalheiroEsper A
Soggetto topico Epilepsy
Drug resistance
ISBN 1-4614-6464-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Pharmacoresistance and Epilepsy -- Genes involved in pharmacoresistant epilepsy -- Pathological oscillations in the pharmacoresistant epileptic brain -- Molecular mechanisms of pharmacoresistant epilepsy -- Modifications in the seizures susceptibility by excitotoxic neuronal damage and its possible relationship with the pharmacoresistance -- Intracellular pathways associated with neuronal survival and death in epilepsy -- The role of JNK pathway in the process of excitotoxicity induced by epilepsy and neurodegeneration -- Proteomics-based strategy to identify biomarkers and pharmacological targets in temporal lobe epilepsy -- Abnormalities of GABA system and human pharmacoresistant epilepsy -- Pharmacoresistant epilepsy and immune system -- Contribution of the antiepileptic drug administration regime in the development and/or establishment of pharmacoresistant epilepsy -- Experimental models to study pharmacoresistance in epilepsy -- Resistance to epileptogenesis in the Neotropical rodent Proechimys -- On the development of new antiepileptic drugs for the treatment of pharmacoresistant epilepsy – Different approaches to different hypothesis -- Modulating P-glycoprotein regulation as a therapeutic strategy for pharmacoresistant epilepsy -- Vagus Nerve Stimulation for Intractable Seizures -- The role of neuromodulation in the treatment of refractory epilepsy -- Transcranial magnetic stimulation and refractory partial epilepsy -- Effects of transcranial focal electrical stimulation via concentric ring electrodes on seizure activity -- Physical exercise as a strategy to reduce seizure susceptibility.
Record Nr. UNINA-9910737299803321
New York, : Springer, c2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui